In the per-protocol population , 116 ( 45 % ) of 258 patients and 134 ( 51 % ) of 263 patients , respectively , had an overall pain response to treatment ( p = 017 ; response difference 600 % [ upper limit of the 95 % CI 132 , greater than the prespecified non-inferiority margin of 10 % ] ) .